Evox Therapeutics Names Co-Founder Dr. Per Lundin as Chief Executive Officer
29. April 2024 02:00 ET
|
EVOX THERAPEUTICS LIMITED
Evox Therapeutics announces the appointment of Dr. Per Lundin as Chief Executive Officer
Landmark paper in Nature Communications highlights continued advances in Evox Therapeutics’s proprietary exosome engineering platform
09. August 2023 02:00 ET
|
EVOX THERAPEUTICS LIMITED
OXFORD, United Kingdom, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd ('Evox'), a leading exosome therapeutics company, today announced the publication in Nature Communications of...
Evox Therapeutics enters into agreement to advance next generation exosome-delivered AAV gene therapy for the treatment of heart disease
04. August 2023 02:00 ET
|
EVOX THERAPEUTICS LIMITED
OXFORD, United Kingdom, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd ('Evox'), a leading exosome therapeutics company, today announced a research collaboration and option agreement with...
Evox Therapeutics Acquires Exosome AAV Technology and Intellectual Property
20. Juni 2023 02:00 ET
|
EVOX THERAPEUTICS LIMITED
IP bolsters Company’s already dominant and broad position with respect to exosome therapeutics Acquisition is in line with long-term strategy to improve exosome-mediated delivery to enable novel gene...
Evox Therapeutics Granted Key US Exosome Purification Patent to Further Expand Its Leading Patent Portfolio
17. Mai 2023 08:00 ET
|
EVOX THERAPEUTICS LIMITED
OXFORD, United Kingdom, May 17, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announced that the Company has been granted...
Evox Therapeutics Presents Progress Across its DeliverEX® Platform Highlighting Advances in Exosome-Mediated Delivery of Genetic Medicines Including Gene Editing and RNA Therapeutics
12. Mai 2023 08:00 ET
|
EVOX THERAPEUTICS LIMITED
OXFORD, United Kingdom, May 12, 2023 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, will present data at two upcoming international...
Evox Therapeutics Expands its Exosome Manufacturing Patent Portfolio
07. September 2022 07:00 ET
|
EVOX THERAPEUTICS LIMITED
OXFORD, United Kingdom, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announced that the Company has been granted...
Evox Therapeutics Presents Progress Across its DeliverEX™ Exosome Therapeutics Platform with Nine Presentations at the International Society for Extracellular Vesicles (ISEV) Annual Meeting
26. Mai 2022 03:00 ET
|
EVOX THERAPEUTICS LIMITED
OXFORD, United Kingdom, May 26, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, announced advances in exosome engineering,...
Evox Therapeutics to Present at the 2022 Jefferies Healthcare Conference
24. Mai 2022 08:00 ET
|
EVOX THERAPEUTICS LIMITED
OXFORD, United Kingdom, May 24, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, will participate in the 2022 Jefferies Healthcare...
Evox Therapeutics Announces Data Presentations at the International Society for Extracellular Vesicles (ISEV) Annual Meeting
19. Mai 2022 08:00 ET
|
EVOX THERAPEUTICS LIMITED
OXFORD, United Kingdom, May 19, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, announced titles of nine abstracts to be presented...